Anantha Shekhar,MD, PHD, Senior Vice Chancellor for the Health Sciences at the University of Pittsburgh announced the winners of the inaugural Ascending Stars Award

Gdavis Productions & Films in association with the University of Pittsburgh Alzheimer’s Disease Research Center presents the free live streaming of Garrett Davis’ award winning stage play, Forget Me Not.

We are addressing this to all the family members and friends who provide care for persons living with Alzheimer’s disease and similar dementias. The care you provide is always vital to the quality of life and well-being of that person. The Novel Coronavirus (COVID-19)...

NIH approves a $350 million Alzheimer’s and dementia funding increase for fiscal year 2020.

YMAA was charted in 2015 and is the largest youth-led Alzheimer’s 501 (c)(3) non-profit in the nation.

The disease, called LATE, seems to develop more slowly than Alzheimer’s and to appear later, when people are in their 80s and 90s.

Alzheimer’s disease impacts nearly 6 million Americans. Researchers at the University of Pittsburgh are working to try and figure out why and whether it can be stopped. They say it may start with a walk around the block.

What do we know about AD and how do we treat it? Dr. Jennifer Lingler and Niki Kapsambelis talk to Ken Rice and Sally Stapleton on KD/PG Sunday edition.

Melita Terry,  Alzheimer’s Disease Research Center Outreach Coordinator and Dr. Annie Cohen, Assistant Professor of Psychiatry, both at the University of Pittsburgh, spoke about Alzheimer’s disease at the Urban League Lunch and Learn in February, 2018.

Brain Day is an all-day event that brings together experts from around Pitt to share their work in neuroscience with not only their colleagues, but with the patient advocacy community.

A new clinical trials consortium funded by the National Institutes of Health is expected to accelerate and expand studies for therapies in Alzheimer’s disease and related dementias.

Bill Gates spoke with CNN Chief Medical Correspondent, Dr. Sanjay Gupta about why he plans on donating $50 million of his own money to the Dementia Discovery Fund.

Dr. Jennifer Lingler awarded $2.6 million by the National Institutes of Health to conduct a study addressing racial disparities in Alzheimer’s disease research.

Gary Rothstein of the Pittsburgh Post-Gazette reports on the release of a comprehensive report that analyzed how people might be able to prevent dementia.

ADRC receives $500,000 endowment from the Joseph & Ligia Wiegand Family Foundation

The University of Pittsburgh has started a new Brain Exercise and Training Wellness Program called BRiTE.

Cynthia Patton, journalist  spoke with Dr. Oscar Lopez, director of the Alzheimer’s Disease Research Center at the University of Pittsburgh.

Hugh Papke has been a caregiver for his wife Doris who has had Alzheimer’s for 11 years. Doris is a former participant of the ADRC at the University of Pittsburgh.

The Barcelona-Pittsburgh Symposium on Dementia is held biannually in Barcelona.

In a recent article on MedToday.com Kristina Fiore interviewed former ADRC Director, Steven DeKosky, MD, about his role in research on chronic traumatic encephalopathy (CTE) in professional football players and on events portrayed in the film “Concussion”.

An article on Today.com highlights how simple lifestyle changes may help the mind as well as the body. The January 6, 2016 posting by Linda Carroll identifies seven strategies to keep the brain sharp.

Sophie Wodzak of the Pittsburgh Post-Gazette wrote an article published on October 6, 2015 about Home Instead Senior Care’s new Alzheimer’s Friendly Business Program that strives to reduce the stigma surrounding the disease and supporting families facing the disease in their day-to-day life.

NIH relesead the 2014-2015 Alzheimer’s Disease Progress Report titled Advancing Research Toward a Cure.

A Pittsburgh family beset with an early form of Alzheimer’s Disease shares their experience with this rare variant of the disease.

Frontotemporal Degeneration (FTD) is the most common cause of dementia for people under age 60 – affecting more than 50,000 Americans.

The Lancet Neurology published Longitudinal assessment of neuroimaging and clinical markers in autosomal dominant Alzheimer’s disease: a prospective cohort study authored by Pitt researchers at the ADRC and their colleagues in the August 2015 issue.

The Time to Invest in Alzheimer’s Research Is Now – Next Avenue School grades aged 10 predict risk of dementia – The Telegraph Early signs drug delays Alzheimer’s

Erickson, of Pitt’s Center for the Neural Basis of Cognition and Center for Neuroscience, studies brain function and has published extensively on cognitive changes that occur as a function of physical health and aging.

The evidence is mounting: People can reduce their risk of cognitive decline by making key lifestyle changes.

Doctors at the University of Pittsburgh Alzheimer’s Disease Research Center (ADRC) confirmed Mr. Massaro’s Alzheimer’s disease diagnosis at age 72.

Recent reports have given University of Pittsburgh Alzheimer’s researchers some hope despite the huge challenges that still exist.

The Alzheimer ‘s Association recently reported on the finding that only 45 percent of patients who have Alzheimer’s disease were actually told of their diagnosis versus 90 percent of people with one of four common types of cancer.

William E. Klunk, MD, PhD has been elected to the National Alzheimer’s Association Board of Directors and Chair of the Medical and Scientific Advisory Council for the upcoming 2014-2015 term.

Marita Garrett, Outreach Coordinator at the ADRC, was selected by Pitt’s African American Alumni Council (AAAC) to be one of the recipients of this year’s Rising African American Leaders Award.

A group of experts on Alzheimer’s Disease are contesting the U.S. Government’s pro-active plans to prevent and treat the disease until 2025.

The protracted period from diagnosis to death from Alzheimer’s disease has been called “the long goodbye,” and for good reason.

More and more, caregivers and Alzheimer’s professionals in Washington and Greene counties and throughout the country are using art to engage and connect with people with Alzheimer’s.

Researchers have long wondered why some older people remain cognitively normal despite having abnormal levels of beta-amyloid in their brains, a hallmark of Alzheimer’s disease.

Preliminary findings from a study by National Institute on Aging (NIA) scientists and colleagues showed that a blood test for Alzheimer’s-related proteins may accurately predict who might be at risk for the disease years before symptoms develop.

Every day, your brain contends with a barrage of stimuli that affect your memory, from stress to daily distractions.